Caption Management’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.2K Buy
+1,000
New +$74.2K ﹤0.01% 1417
2025
Q4
Sell
-15,513
Closed -$1.06M 1813
2025
Q3
$522K Sell
15,513
-183,995
-92% -$4.53M ﹤0.01% 1293
2025
Q2
$2.85M Hold
199,508
0.03% 602
2025
Q1
$2.79M Sell
199,508
-390
-0.2% -$5.3K 0.03% 580
2024
Q4
$3.08M Sell
199,898
-100
-0.1% -$1.52K 0.03% 543
2024
Q3
$3.13M Hold
199,998
0.05% 434
2024
Q2
$2.83M Buy
+199,998
New +$3.12M 0.04% 408

Other funds holding INBX

Caption Management's INBX Position: Q1 2026 in Review

Caption Management opened a new position in Inhibrx (INBX) in Q1 2026: 1,000 shares worth $67.2K. The stake represents ﹤0.01% of the portfolio and ranks #1417 among its holdings. This is a return to the name: Caption Management previously reported a position in INBX as recently as Q3 2025.

Caption Management first reported a position in INBX in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.13M in Q3 2024. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Caption Management held 1,000 shares of Inhibrx worth $67.2K as of Q1 2026.
  • Inhibrx was a new Caption Management position in Q1 2026.
  • Inhibrx made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1417 holding.
  • Caption Management first reported a position in Inhibrx in Q2 2024 and has held it in 7 quarters since.
  • Caption Management's Inhibrx position peaked at $3.13M in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.